Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/11/2025
BeOne's Tevimbra Wins EU Green Light for First-Line Nasopharyngeal Can...
7/11/2025
Haleon Secures Full Ownership of Tianjin Sino‑American JV
7/11/2025
TandemAI and Perpetual Medicine Announce Strategic Merger
7/10/2025
China's Rising Biotechnology Sector: Friend or Foe? (EGGI)
7/9/2025
Simcere Advances Rademikibart with NDA Submission for Atopic Dermatiti...
7/8/2025
China's Biotech Financing Hits 10-Year Low in First Half of 2025
7/8/2025
CStone and Istituto Gentili Forge Partnership for Sugemalimab in Weste...
7/8/2025
China Hospitals Prioritize Local Innovation, Digital Health, and Profi...
7/8/2025
Fosun USA and MAP International Partner to Expand Medicine Access
7/8/2025
XellSmart Completes New Financing, Secures FDA Clearance for iPSC-Deri...
7/8/2025
Novo Nordisk Commits CNY 800M to Expand Quality Lab at Tianjin Manufac...
7/8/2025
As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...
7/4/2025
Shaanxi Micot Secures 100M CNY in Series D Financing
7/4/2025
AstraZeneca Eyes $15B Deal for Summit's Chinese-Developed Lung Cancer ...
7/3/2025
Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...
7/3/2025
Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...
7/2/2025
Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...
7/2/2025
NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...
7/2/2025
Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...
7/1/2025
Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...
7/1/2025
Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...
7/1/2025
NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...
7/1/2025
Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...
7/1/2025
Hengrui's Ivarmacitinib Approved in China for Severe Alopecia Areata
7/1/2025
Revolution Medicines and Summit Therapeutics Launch RAS-Targeting Comb...
7/1/2025
Zai Lab-Backed FORTITUDE-101 Trial Hits Key Milestone in...
7/1/2025
China Launches New Tax Incentives to Boost Foreign Companies' Reinvest...
7/1/2025
Jinhua Conba and EVA Forge Strategic Partnership to Strengthen China-M...
7/1/2025
Record China Pharma Monopoly Fine Sends Strong Deterrent Signal, Exper...
7/1/2025
China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
Page:
3
/
363
Total number of articles:
10881
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit